Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
Recruiting now NCT05188027
Run by University of Alberta · for 45 to 75 · Women
What this study is about
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.
Who can join (things the study team will check)
✅ You may be able to join if…
- type 1 diabetes, diagnosed for at least one year
- post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
- able to perform aerobic and resistance exercise
- able to visit the lab in Edmonton, Alberta (University of Alberta)
🚫 You may not be able to join if…
- HbA1c > 9.9 %
- frequent and unpredictable hypoglycemia
- change in insulin management strategy within the last 2 months
- blood pressure > 140 / 95
- severe peripheral neuropathy
- history of cardiovascular disease
- musculoskeletal injuries interfering with exercise performance
- use of medications (other than insulin) that affect glucose metabolism
- BMI > 30 kg/m2
- smoking
- moderate to high alcohol intake (> 2 drinks/day)
Where this trial is running
- Alberta Diabetes Institute, Edmonton, Alberta, Canada
- Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada
Who to contact
Jane E Yardley, PhD · 780-679-1688 · jane.yardley@ualberta.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05188027.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.